TAMARACK ADVISERS, LP Holdings

TAMARACK ADVISERS, LP is an investment fund managing more than 170.32M US dollars. The largest holdings include Lantheus Holdings, Allscripts Healthcare Solutions and Pacira BioSciences. In Q3 2022 the fund bought assets of total value of 40.17M US dollars and sold assets of total value of 43.2M US dollars.

$170.31M

portfolio value

-2.42%

quarter

-16.74%

1 year

+27.17%

3 years

+103.33%

5 years

TAMARACK ADVISERS, LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	34956000	225986000
Q2 2016	77788000	104380000
Q3 2016	120127000	47050000
Q4 2016	33544000	172448000
Q1 2017	61683000	34481000
Q2 2017	29636000	15560000
Q3 2017	43926000	42711000
Q4 2017	51672000	30599000
Q1 2018	106106000	76249000
Q2 2018	149417000	59388000
Q3 2018	67725000	19791000
Q4 2018	5279000	89123000
Q1 2019	81766000	61607000
Q2 2019	116123000	38877000
Q3 2019	81858000	24587000
Q4 2019	91842000	35838000
Q1 2020	63281000	242236000
Q2 2020	129361000	31861000
Q3 2020	60292000	83381000
Q4 2020	154326000	11644000
Q1 2021	136865000	123184000
Q2 2021	70232000	191246000
Q3 2021	47302000	80068000
Q4 2021	91305000	148567000
Q1 2022	62120000	100582000
Q2 2022	48137000	81842000
Q3 2022	40168000	43201000

TAMARACK ADVISERS, LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Drug Manufacturers—Specialty & Generic Lantheus Holdings, Inc. Portfolio share: 8.59% Portfolio value: 14.62M Avg. open price: $14.53 Current price: $56.01 P/L: +285.57% Sold -16.80% shares Q3 2022	share	8.59%	14.62M	$14.53	$56.01	+285.57%	Sold -16.80% shares Q3 2022
Health Information Services Allscripts Healthcare Solutions, Inc. Portfolio share: 6.13% Portfolio value: 10.43M Avg. open price: $12.86 Current price: $18.7 P/L: +45.44% Bought +24.55% shares Q3 2022	share	6.13%	10.43M	$12.86	$18.7	+45.44%	Bought +24.55% shares Q3 2022
Drug Manufacturers—Specialty & Generic Pacira BioSciences, Inc. Portfolio share: 6.09% Portfolio value: 10.37M Avg. open price: $39.46 Current price: $46.75 P/L: +18.46% Bought +11.43% shares Q3 2022	share	6.09%	10.37M	$39.46	$46.75	+18.46%	Bought +11.43% shares Q3 2022
Drug Manufacturers—Specialty & Generic Perrigo Company plc Portfolio share: 5.34% Portfolio value: 9.09M Avg. open price: $44.39 Current price: $31.81 P/L: -28.35% Bought +27.50% shares Q3 2022	share	5.34%	9.09M	$44.39	$31.81	-28.35%	Bought +27.50% shares Q3 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 5.30% Portfolio value: 9.02M Avg. open price: $72.89 Current price: $44.6 P/L: -38.81% Bought +9.38% shares Q3 2022	share	5.30%	9.02M	$72.89	$44.6	-38.81%	Bought +9.38% shares Q3 2022
Medical Devices Cerus Corporation Portfolio share: 5.13% Portfolio value: 8.73M Avg. open price: $6.1 Current price: $3.99 P/L: -34.55% Bought +21.25% shares Q3 2022	share	5.13%	8.73M	$6.1	$3.99	-34.55%	Bought +21.25% shares Q3 2022
Medical Devices SI-BONE, Inc. Portfolio share: 4.72% Portfolio value: 8.03M Avg. open price: $23.13 Current price: $12.08 P/L: -47.77% Sold -14.02% shares Q3 2022	share	4.72%	8.03M	$23.13	$12.08	-47.77%	Sold -14.02% shares Q3 2022
Medical Instruments & Supplies AngioDynamics, Inc. Portfolio share: 3.90% Portfolio value: 6.65M Avg. open price: $26.42 Current price: $12.06 P/L: -54.36% Bought +1.56% shares Q3 2022	share	3.90%	6.65M	$26.42	$12.06	-54.36%	Bought +1.56% shares Q3 2022
Health Information Services Phreesia, Inc. Portfolio share: 3.89% Portfolio value: 6.62M Avg. open price: $26.12 Current price: $28.04 P/L: +7.33% Bought +6.12% shares Q3 2022	share	3.89%	6.62M	$26.12	$28.04	+7.33%	Bought +6.12% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 3.53% Portfolio value: 6.01M Avg. open price: $82.87 Current price: $103.53 P/L: +24.93% Bought +136.67% shares Q3 2022	share	3.53%	6.01M	$82.87	$103.53	+24.93%	Bought +136.67% shares Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 3.46% Portfolio value: 5.89M Avg. open price: $50.03 Current price: $44.93 P/L: -10.19% Bought +63.16% shares Q3 2022	share	3.46%	5.89M	$50.03	$44.93	-10.19%	Bought +63.16% shares Q3 2022
Health Information Services Streamline Health Solutions, Inc. Portfolio share: 3.45% Portfolio value: 5.86M Avg. open price: $1.24 Current price: $1.98 P/L: +59.12% N/A Q3 2022	share	3.45%	5.86M	$1.24	$1.98	+59.12%	N/A Q3 2022
Healthcare Plans CIGNA CORP Portfolio share: 3.26% Portfolio value: 5.54M Avg. open price: $230.75 Current price: $327.39 P/L: +41.88% Sold -68.25% shares Q3 2022	share	3.26%	5.54M	$230.75	$327.39	+41.88%	Sold -68.25% shares Q3 2022
Drug Manufacturers—Specialty & Generic Viatris Inc. Portfolio share: 3.25% Portfolio value: 5.53M Avg. open price: $12.35 Current price: $10.92 P/L: -11.59% Bought +85.71% shares Q3 2022	share	3.25%	5.53M	$12.35	$10.92	-11.59%	Bought +85.71% shares Q3 2022
Medical Devices Bioventus Inc. Portfolio share: 3.08% Portfolio value: 5.25M Avg. open price: $14.2 Current price: $2.25 P/L: -84.16% Sold -9.09% shares Q2 2022	share	3.08%	5.25M	$14.2	$2.25	-84.16%	Sold -9.09% shares Q2 2022
Drug Manufacturers—Specialty & Generic Collegium Pharmaceutical, Inc. Portfolio share: 2.82% Portfolio value: 4.80M Avg. open price: $17.72 Current price: $22.73 P/L: +28.27% Bought +200.00% shares Q3 2022	share	2.82%	4.80M	$17.72	$22.73	+28.27%	Bought +200.00% shares Q3 2022
Healthcare Plans CVS Health Corporation Portfolio share: 2.80% Portfolio value: 4.76M Avg. open price: $103.68 Current price: $102.01 P/L: -1.61% N/A Q3 2022	share	2.80%	4.76M	$103.68	$102.01	-1.61%	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Alkermes plc Portfolio share: 2.62% Portfolio value: 4.46M Avg. open price: $79.13 Current price: $25.51 P/L: -67.76% N/A Q3 2022	share	2.62%	4.46M	$79.13	$25.51	-67.76%	N/A Q3 2022
Biotechnology Jazz Pharmaceuticals plc Portfolio share: 2.35% Portfolio value: 3.99M Avg. open price: $156.01 Current price: $150.97 P/L: -3.23% Bought +20.00% shares Q3 2022	share	2.35%	3.99M	$156.01	$150.97	-3.23%	Bought +20.00% shares Q3 2022
Medical Care Facilities DocGo Inc. Portfolio share: 2.18% Portfolio value: 3.72M Avg. open price: $7.66 Current price: $6.84 P/L: -10.68% Bought +114.29% shares Q3 2022	share	2.18%	3.72M	$7.66	$6.84	-10.68%	Bought +114.29% shares Q3 2022
Tobacco Turning Point Brands, Inc. Portfolio share: 2.06% Portfolio value: 3.50M Avg. open price: $30.33 Current price: $21.8 P/L: -28.12% Sold -13.16% shares Q3 2022	share	2.06%	3.50M	$30.33	$21.8	-28.12%	Sold -13.16% shares Q3 2022
Medical Instruments & Supplies AtriCure, Inc. Portfolio share: 1.55% Portfolio value: 2.63M Avg. open price: $32.3 Current price: $43.65 P/L: +35.16% Sold -32.50% shares Q3 2022	share	1.55%	2.63M	$32.3	$43.65	+35.16%	Sold -32.50% shares Q3 2022
Biotechnology Rigel Pharmaceuticals, Inc. Portfolio share: 1.39% Portfolio value: 2.36M Avg. open price: $2.72 Current price: $0.95 P/L: -65.08% Sold -38.46% shares Q2 2022	share	1.39%	2.36M	$2.72	$0.95	-65.08%	Sold -38.46% shares Q2 2022
Medical Instruments & Supplies ICU Medical, Inc. Portfolio share: 1.33% Portfolio value: 2.25M Avg. open price: $186.6 Current price: $156.19 P/L: -16.30% Bought +15.38% shares Q3 2022	share	1.33%	2.25M	$186.6	$156.19	-16.30%	Bought +15.38% shares Q3 2022
Drug Manufacturers—General Merck & Co., Inc. Portfolio share: 1.26% Portfolio value: 2.15M Avg. open price: $77.14 Current price: $110.01 P/L: +42.61% Sold -66.67% shares Q3 2022	share	1.26%	2.15M	$77.14	$110.01	+42.61%	Sold -66.67% shares Q3 2022
Healthcare Plans Molina Healthcare, Inc. Portfolio share: 1.16% Portfolio value: 1.97M Avg. open price: N/A Current price: $335.11 P/L: N/A N/A Q3 2022	share	1.16%	1.97M	N/A	$335.11	N/A	N/A Q3 2022
Diagnostics & Research IQVIA Holdings Inc. Portfolio share: 1.06% Portfolio value: 1.81M Avg. open price: N/A Current price: $211.93 P/L: N/A N/A Q3 2022	share	1.06%	1.81M	N/A	$211.93	N/A	N/A Q3 2022
Medical Devices Tactile Systems Technology, Inc. Portfolio share: 1.03% Portfolio value: 1.75M Avg. open price: $13.87 Current price: $10.05 P/L: -27.55% Bought +28.57% shares Q3 2022	share	1.03%	1.75M	$13.87	$10.05	-27.55%	Bought +28.57% shares Q3 2022
Electronic Components Plexus Corp. Portfolio share: 1.03% Portfolio value: 1.75M Avg. open price: $76.46 Current price: $108.08 P/L: +41.36% Bought +233.33% shares Q3 2022	share	1.03%	1.75M	$76.46	$108.08	+41.36%	Bought +233.33% shares Q3 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 0.91% Portfolio value: 1.54M Avg. open price: N/A Current price: $119.41 P/L: N/A N/A Q2 2022	share	0.91%	1.54M	N/A	$119.41	N/A	N/A Q2 2022
Biotechnology Fennec Pharmaceuticals Inc. Portfolio share: 0.83% Portfolio value: 1.41M Avg. open price: N/A Current price: $9.57 P/L: N/A N/A Q3 2022	share	0.83%	1.41M	N/A	$9.57	N/A	N/A Q3 2022
Diagnostics & Research RadNet, Inc. Portfolio share: 0.72% Portfolio value: 1.22M Avg. open price: $11.79 Current price: $21.05 P/L: +78.52% Bought +20.00% shares Q3 2022	share	0.72%	1.22M	$11.79	$21.05	+78.52%	Bought +20.00% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.53% Portfolio value: 897K Avg. open price: $16.44 Current price: $21.89 P/L: +33.15% Sold -75.00% shares Q3 2022	share	0.53%	897K	$16.44	$21.89	+33.15%	Sold -75.00% shares Q3 2022
Health Information Services SomaLogic, Inc. Portfolio share: 0.51% Portfolio value: 870K Avg. open price: $10.39 Current price: $2.7 P/L: -74.02% Sold -14.29% shares Q3 2022	share	0.51%	870K	$10.39	$2.7	-74.02%	Sold -14.29% shares Q3 2022
Medical Devices Bio-Rad Laboratories, Inc. Portfolio share: 0.49% Portfolio value: 834K Avg. open price: $242.68 Current price: $405.79 P/L: +67.22% N/A Q3 2022	share	0.49%	834K	$242.68	$405.79	+67.22%	N/A Q3 2022
Medical Instruments & Supplies Envista Holdings Corporation Portfolio share: 0.48% Portfolio value: 820K Avg. open price: N/A Current price: $33.51 P/L: N/A N/A Q3 2022	share	0.48%	820K	N/A	$33.51	N/A	N/A Q3 2022
Diagnostics & Research DermTech, Inc. Portfolio share: 0.41% Portfolio value: 693K Avg. open price: $24.06 Current price: $2.46 P/L: -89.77% Bought +75.00% shares Q3 2022	share	0.41%	693K	$24.06	$2.46	-89.77%	Bought +75.00% shares Q3 2022
Medical Instruments & Supplies Becton, Dickinson and Company Portfolio share: 0.40% Portfolio value: 680K Avg. open price: N/A Current price: $246.21 P/L: N/A N/A Q3 2022	put	0.40%	680K	N/A	$246.21	N/A	N/A Q3 2022
Medical Devices MaxCyte, Inc. Portfolio share: 0.31% Portfolio value: 534K Avg. open price: N/A Current price: $5.43 P/L: N/A N/A Q3 2022	share	0.31%	534K	N/A	$5.43	N/A	N/A Q3 2022
Diagnostics & Research CareDx, Inc Portfolio share: 0.25% Portfolio value: 426K Avg. open price: N/A Current price: $12.53 P/L: N/A N/A Q2 2022	share	0.25%	426K	N/A	$12.53	N/A	N/A Q2 2022
Medical Devices ViewRay, Inc. Portfolio share: 0.21% Portfolio value: 364K Avg. open price: N/A Current price: $4.63 P/L: N/A Sold -75.00% shares Q3 2022	share	0.21%	364K	N/A	$4.63	N/A	Sold -75.00% shares Q3 2022
SPDR S&P 500 ETF Trust Portfolio share: 0.07% Portfolio value: 125K Avg. open price: $313.74 Current price: $400.01 P/L: +27.50% N/A Q3 2022	put	0.07%	125K	$313.74	$400.01	+27.50%	N/A Q3 2022
Drug Manufacturers—Specialty & Generic TerrAscend Corp. Portfolio share: 0.06% Portfolio value: 96K Avg. open price: N/A Current price: $2.24 P/L: N/A Sold -50.00% shares Q1 2022	share	0.06%	96K	N/A	$2.24	N/A	Sold -50.00% shares Q1 2022
iShares iBonds Dec 2024 Term Treasury ETF Portfolio share: 0.04% Portfolio value: 76K Avg. open price: $24.43 Current price: $23.86 P/L: -2.33% Bought +60.00% shares Q3 2022	call	0.04%	76K	$24.43	$23.86	-2.33%	Bought +60.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Viatris Inc. Portfolio share: 0.02% Portfolio value: 30K Avg. open price: $12.35 Current price: $10.92 P/L: -11.59% N/A Q3 2022	call	0.02%	30K	$12.35	$10.92	-11.59%	N/A Q3 2022
CM LIFE SCIENCES II -CW27 Portfolio share: 0.01% Portfolio value: 9K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	0.01%	9K	N/A	N/A	N/A	N/A Q2 2022
Biotechnology United Therapeutics Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $88.31 Current price: $273.72 P/L: +209.95% Sold -100.00% shares Q3 2022	share	0.00%	0	$88.31	$273.72	+209.95%	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Trulieve Cannabis Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $14.96 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$14.96	N/A	Sold -100.00% shares Q3 2022
SPDR Gold Shares Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $172.3 Current price: $164.39 P/L: -4.59% Sold -100.00% shares Q3 2022	call	0.00%	0	$172.3	$164.39	-4.59%	Sold -100.00% shares Q3 2022
Diagnostics & Research Laboratory Corporation of America Holdings Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $167.16 Current price: $236.39 P/L: +41.41% Sold -100.00% shares Q3 2022	share	0.00%	0	$167.16	$236.39	+41.41%	Sold -100.00% shares Q3 2022
Health Information Services NextGen Healthcare, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $20.91 Current price: $20.13 P/L: -3.73% Sold -100.00% shares Q3 2022	share	0.00%	0	$20.91	$20.13	-3.73%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Amgen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $285.01 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$285.01	N/A	Sold -100.00% shares Q3 2022
Medical Devices InMode Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $70.19 Current price: $36.66 P/L: -47.77% Sold -100.00% shares Q3 2022	share	0.00%	0	$70.19	$36.66	-47.77%	Sold -100.00% shares Q3 2022

Showing TOP 53 TAMARACK ADVISERS, LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of TAMARACK ADVISERS, LP?

The biggest position of the TAMARACK ADVISERS, LP is Lantheus Holdings, Inc. (LNTH) with 8.59% portfolio share worth of 14.63M US dollars.

Top 5 TAMARACK ADVISERS, LP's holdings represent 31.44% of the portfolio:

Lantheus Holdings, Inc. (LNTH) – 8.59%
Allscripts Healthcare Solutions, Inc. (MDRX) – 6.13%
Pacira BioSciences, Inc. (PCRX) – 6.09%
Perrigo Company plc (PRGO) – 5.34%
Tenet Healthcare Corporation (THC) – 5.3%

Who is the portfolio manager of TAMARACK ADVISERS, LP?

The portfolio manager of the TAMARACK ADVISERS, LP is .

What is the total asset value of the TAMARACK ADVISERS, LP portfolio?

TAMARACK ADVISERS, LP total asset value (portfolio value) is 170.32M US dollars.

Who is ?

is the portfolio manager of the TAMARACK ADVISERS, LP.

What is (TAMARACK ADVISERS, LP) fund performance?

TAMARACK ADVISERS, LP's quarterly performance is -2.42%, annualy -16.74%. In the past 3 years, the value of 's portfolio has increased by +27%. In the past 5 years, the value of the portfolio has increased by +103%.

What is the TAMARACK ADVISERS, LP CIK?

TAMARACK ADVISERS, LP's Central Index Key is 0001661462 .

TAMARACK ADVISERS, LP Holdings

TAMARACK ADVISERS, LP portfolio value:

TAMARACK ADVISERS, LP quarter portfolio value change:

TAMARACK ADVISERS, LP 1 year portfolio value change:

TAMARACK ADVISERS, LP 3 years portfolio value change:

TAMARACK ADVISERS, LP 5 years portfolio value change: